<?xml version='1.0' encoding='utf-8'?>
<document id="32132876"><sentence text="Drug-drug interaction of acetaminophen and roxithromycin with the cocktail of cytochrome P450 and hepatotoxicity in rats."><entity charOffset="25-38" id="DDI-PubMed.32132876.s1.e0" text="acetaminophen" /><entity charOffset="43-56" id="DDI-PubMed.32132876.s1.e1" text="roxithromycin" /><pair ddi="false" e1="DDI-PubMed.32132876.s1.e0" e2="DDI-PubMed.32132876.s1.e0" /><pair ddi="false" e1="DDI-PubMed.32132876.s1.e0" e2="DDI-PubMed.32132876.s1.e1" /></sentence><sentence text="Acetaminophen (APAP) and roxithromycin (ROX) are often used in combination in clinical practice"><entity charOffset="0-13" id="DDI-PubMed.32132876.s2.e0" text="Acetaminophen" /><entity charOffset="15-19" id="DDI-PubMed.32132876.s2.e1" text="APAP" /><entity charOffset="25-38" id="DDI-PubMed.32132876.s2.e2" text="roxithromycin" /><entity charOffset="40-43" id="DDI-PubMed.32132876.s2.e3" text="ROX" /><pair ddi="false" e1="DDI-PubMed.32132876.s2.e0" e2="DDI-PubMed.32132876.s2.e0" /><pair ddi="false" e1="DDI-PubMed.32132876.s2.e0" e2="DDI-PubMed.32132876.s2.e1" /><pair ddi="false" e1="DDI-PubMed.32132876.s2.e0" e2="DDI-PubMed.32132876.s2.e2" /><pair ddi="false" e1="DDI-PubMed.32132876.s2.e0" e2="DDI-PubMed.32132876.s2.e3" /><pair ddi="false" e1="DDI-PubMed.32132876.s2.e1" e2="DDI-PubMed.32132876.s2.e1" /><pair ddi="false" e1="DDI-PubMed.32132876.s2.e1" e2="DDI-PubMed.32132876.s2.e2" /><pair ddi="false" e1="DDI-PubMed.32132876.s2.e1" e2="DDI-PubMed.32132876.s2.e3" /><pair ddi="false" e1="DDI-PubMed.32132876.s2.e2" e2="DDI-PubMed.32132876.s2.e2" /><pair ddi="false" e1="DDI-PubMed.32132876.s2.e2" e2="DDI-PubMed.32132876.s2.e3" /></sentence><sentence text=" To evaluate their drug-drug interactions (DDIs) and the hepatotoxicity of co-administration, rats were randomly separated into four groups: Control, APAP (50 mg/kg), ROX (5"><entity charOffset="150-152" id="DDI-PubMed.32132876.s3.e0" text="APAP" /><entity charOffset="167-169" id="DDI-PubMed.32132876.s3.e1" text="ROX" /><pair ddi="false" e1="DDI-PubMed.32132876.s3.e0" e2="DDI-PubMed.32132876.s3.e0" /><pair ddi="false" e1="DDI-PubMed.32132876.s3.e0" e2="DDI-PubMed.32132876.s3.e1" /></sentence><sentence text="5 mg/kg) and APAP-ROX (50 mg/kg and 5"><entity charOffset="13-15" id="DDI-PubMed.32132876.s4.e0" text="APAP" /><entity charOffset="18-20" id="DDI-PubMed.32132876.s4.e1" text="ROX" /><pair ddi="false" e1="DDI-PubMed.32132876.s4.e0" e2="DDI-PubMed.32132876.s4.e0" /><pair ddi="false" e1="DDI-PubMed.32132876.s4.e0" e2="DDI-PubMed.32132876.s4.e1" /></sentence><sentence text="5 mg/kg, respectively)" /><sentence text=" The pharmacokinetic parameters between APAP and ROX were assayed by HPLC, and a cocktail method was used to evaluate the activities of cytochrome (CYP) 450"><entity charOffset="40-42" id="DDI-PubMed.32132876.s6.e0" text="APAP" /><entity charOffset="49-51" id="DDI-PubMed.32132876.s6.e1" text="ROX" /><pair ddi="false" e1="DDI-PubMed.32132876.s6.e0" e2="DDI-PubMed.32132876.s6.e0" /><pair ddi="false" e1="DDI-PubMed.32132876.s6.e0" e2="DDI-PubMed.32132876.s6.e1" /></sentence><sentence text=" The liver microsome CYP2E1 protein was detected using Western blot" /><sentence text=" The levels of plasma parameters, mRNA levels of inflammatory factors (TNF-α, INF-γ, VCAM-1, CXCL-1 and STAT-3) and antioxidant factors (Nrf-2, GSTA, GCLC-1, HO-1 and NQO1) were determined using real-time PCR, along with the observation on histopathological changes in the liver tissue" /><sentence text=" APAP and ROX co-treatment significantly increased CYP2E1 activity, decreased CYP2D6 activity and prolonged APAP and ROX clearance"><entity charOffset="1-3" id="DDI-PubMed.32132876.s9.e0" text="APAP" /><entity charOffset="108-110" id="DDI-PubMed.32132876.s9.e1" text="APAP" /><entity charOffset="10-12" id="DDI-PubMed.32132876.s9.e2" text="ROX" /><entity charOffset="117-119" id="DDI-PubMed.32132876.s9.e3" text="ROX" /><pair ddi="false" e1="DDI-PubMed.32132876.s9.e0" e2="DDI-PubMed.32132876.s9.e0" /><pair ddi="false" e1="DDI-PubMed.32132876.s9.e0" e2="DDI-PubMed.32132876.s9.e2" /><pair ddi="false" e1="DDI-PubMed.32132876.s9.e0" e2="DDI-PubMed.32132876.s9.e1" /><pair ddi="false" e1="DDI-PubMed.32132876.s9.e0" e2="DDI-PubMed.32132876.s9.e3" /><pair ddi="false" e1="DDI-PubMed.32132876.s9.e2" e2="DDI-PubMed.32132876.s9.e2" /><pair ddi="false" e1="DDI-PubMed.32132876.s9.e2" e2="DDI-PubMed.32132876.s9.e1" /><pair ddi="false" e1="DDI-PubMed.32132876.s9.e2" e2="DDI-PubMed.32132876.s9.e3" /><pair ddi="false" e1="DDI-PubMed.32132876.s9.e1" e2="DDI-PubMed.32132876.s9.e1" /><pair ddi="false" e1="DDI-PubMed.32132876.s9.e1" e2="DDI-PubMed.32132876.s9.e3" /></sentence><sentence text=" Co-treatment increased mRNA expressions of TNF-α, NQO1 and MDA while decreasing GPX and SOD levels" /><sentence text=" Histopathological evidence showed the changes of liver tissues in terms of structure, size and tight arrangement" /><sentence text=" This study confirmed that a combination of APAP and ROX inhibited APAP metabolism and that the peak concentration of ROX was delayed"><entity charOffset="44-46" id="DDI-PubMed.32132876.s12.e0" text="APAP" /><entity charOffset="67-69" id="DDI-PubMed.32132876.s12.e1" text="APAP" /><entity charOffset="53-55" id="DDI-PubMed.32132876.s12.e2" text="ROX" /><entity charOffset="118-120" id="DDI-PubMed.32132876.s12.e3" text="ROX" /><pair ddi="false" e1="DDI-PubMed.32132876.s12.e0" e2="DDI-PubMed.32132876.s12.e0" /><pair ddi="false" e1="DDI-PubMed.32132876.s12.e0" e2="DDI-PubMed.32132876.s12.e2" /><pair ddi="false" e1="DDI-PubMed.32132876.s12.e0" e2="DDI-PubMed.32132876.s12.e1" /><pair ddi="false" e1="DDI-PubMed.32132876.s12.e0" e2="DDI-PubMed.32132876.s12.e3" /><pair ddi="false" e1="DDI-PubMed.32132876.s12.e2" e2="DDI-PubMed.32132876.s12.e2" /><pair ddi="false" e1="DDI-PubMed.32132876.s12.e2" e2="DDI-PubMed.32132876.s12.e1" /><pair ddi="false" e1="DDI-PubMed.32132876.s12.e2" e2="DDI-PubMed.32132876.s12.e3" /><pair ddi="false" e1="DDI-PubMed.32132876.s12.e1" e2="DDI-PubMed.32132876.s12.e1" /><pair ddi="false" e1="DDI-PubMed.32132876.s12.e1" e2="DDI-PubMed.32132876.s12.e3" /></sentence><sentence text=" The resulting high level of CYP2E1 may induce oxidative stress and cause liver damage" /><sentence text="" /></document>